The Institutes For Pharmaceutical Discovery L L C - Branford, Connecticut 06405

The Institutes For Pharmaceutical Discovery L L C is categorized under Research and Development Laboratories in Branford, CT .

Business Name: The Institutes For Pharmaceutical Discovery L L C
Contact Person: James M Noland
Address: 23 Business Park Drive, Branford, Connecticut 06405
Phone Number: (203) 315-4000
Website Address: iba-analytics.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founding Year: 1995
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:
Related Businesses: Coolpac Inc - Branford, CT 06405
Booth Development Inc - Branford, CT 06405
Block Island Technologies - Branford, CT 06405
Gigacyte - Branford, CT 06405
Micronet Technology Inc - Branford, CT 06405
Easton Technologies - Branford, CT 06405
Neurogen Corporation - Branford, CT 06405
Division 3 Technologies - Branford, CT 06405
Development Booth - Branford, CT 06405
Shoreline Shellfish LLC - Branford, CT 06405
Curagen Corporation - Branford, CT 06405

The company The Institutes For Pharmaceutical Discovery L L C provides B2B services in the form of Research and Development Laboratories from its single location in Connecticut. 1 to 4 employees work for The Institutes For Pharmaceutical Discovery L L C, and the business now earns $2.500.000 to $4.999.999 per annum.

The Institutes For Pharmaceutical Discovery L L C was launched in 1995 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 . To contact The Institutes For Pharmaceutical Discovery L L C, please call James M Noland with the phone number (203) 315-4000 or visit its single location at 23 Business Park Drive in Branford, Connecticut 06405.

The location of the single location can also be found using the coordinates 41.29601,-72.771259. Read more details about this business on the webpage iba-analytics.com or follow the company’s social media accounts, on Twitter and on Facebook.